Cidara Therapeutics Inc
NASDAQ:CDTX

Watchlist Manager
Cidara Therapeutics Inc Logo
Cidara Therapeutics Inc
NASDAQ:CDTX
Watchlist
Price: 220.86 USD 0% Market Closed
Market Cap: 6.9B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CDTX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CDTX Intrinsic Value
Not Available
Base Case Scenario
Compare CDTX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CDTX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cidara Therapeutics Inc

Current Assets 442.8m
Cash & Short-Term Investments 420m
Receivables 1.9m
Other Current Assets 20.9m
Non-Current Assets 75.8m
Long-Term Investments 50.2m
PP&E 2.1m
Other Non-Current Assets 23.6m
Current Liabilities 95.8m
Accounts Payable 4.4m
Accrued Liabilities 91.5m
Non-Current Liabilities 424k
Other Non-Current Liabilities 424k
Efficiency

Free Cash Flow Analysis
Cidara Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cidara Therapeutics Inc

Revenue
0 USD
Operating Expenses
-150.5m USD
Operating Income
-150.5m USD
Other Expenses
-34.3m USD
Net Income
-184.7m USD
Fundamental Scores

CDTX Profitability Score
Profitability Due Diligence

Cidara Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Sustainable 3Y Average Gross Margin
Negative 3Y Average Net Margin
hidden
Profitability
Score

Cidara Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CDTX Solvency Score
Solvency Due Diligence

Cidara Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Cidara Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CDTX Price Targets Summary
Cidara Therapeutics Inc

Wall Street analysts forecast CDTX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDTX is 220.19 USD with a low forecast of 200.99 USD and a high forecast of 232.58 USD.

Lowest
Price Target
200.99 USD
9% Downside
Average
Price Target
220.19 USD
0% Downside
Highest
Price Target
232.58 USD
5% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cidara Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CDTX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CDTX Insider Trading
Buy and sell transactions by insiders

CDTX News

Other Videos